[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fSvElRJVoIzQOZzxo2myfOSipNazUxWzHHMfoWrlE5_w":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":33,"rows":40},"Universidad Miguel Hernandez de Elche",[4],81,false,11,2,1827540,0,78,[14,17,19,22,24,26,28,30],{"name":15,"count":16},"Depressive Symptoms",4,{"name":18,"count":16},"Mood Disorders",{"name":20,"count":21},"Depressive Disorder",3,{"name":23,"count":21},"Anxiety Disorders and Symptoms",{"name":25,"count":21},"Anxiety Disorders",{"name":27,"count":21},"Emotional Disorder",{"name":29,"count":21},"Health Literacy",{"name":31,"count":21},"Overweight",[],[34,35,36,37,38,39],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[41,76,94,112,130,148,166,184,209],{"intervention":42,"totalTrials":43,"cells":44},"Benzodiazepines",1,{"EARLY_PHASE1":45,"PHASE1":47,"PHASE2":49,"PHASE3":51,"PHASE4":53,"NA":55},{"trials":46,"activeCount":11},[],{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[],{"trials":56,"activeCount":11},[57],{"nctId":58,"briefTitle":59,"status":60,"phases":61,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":66,"interventions":69},"NCT03482232","Consequences of Doing What Should Not be Done in Primary Care","COMPLETED",[],"2019-12-05","2020-02-10","2018-10-14",750000,[67,68],"Overdose","Adverse Event",[42,70,71,72,73,72,74,75],"Non-steroidal anti-inflammatory drugs","paracetamol","Antimicrobial agent","Lipid-lowering drug","Mucolytic","Ibuprofen and paracetamol",{"intervention":70,"totalTrials":43,"cells":77},{"EARLY_PHASE1":78,"PHASE1":80,"PHASE2":82,"PHASE3":84,"PHASE4":86,"NA":88},{"trials":79,"activeCount":11},[],{"trials":81,"activeCount":11},[],{"trials":83,"activeCount":11},[],{"trials":85,"activeCount":11},[],{"trials":87,"activeCount":11},[],{"trials":89,"activeCount":11},[90],{"nctId":58,"briefTitle":59,"status":60,"phases":91,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":92,"interventions":93},[],[67,68],[42,70,71,72,73,72,74,75],{"intervention":71,"totalTrials":43,"cells":95},{"EARLY_PHASE1":96,"PHASE1":98,"PHASE2":100,"PHASE3":102,"PHASE4":104,"NA":106},{"trials":97,"activeCount":11},[],{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[],{"trials":103,"activeCount":11},[],{"trials":105,"activeCount":11},[],{"trials":107,"activeCount":11},[108],{"nctId":58,"briefTitle":59,"status":60,"phases":109,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":110,"interventions":111},[],[67,68],[42,70,71,72,73,72,74,75],{"intervention":72,"totalTrials":43,"cells":113},{"EARLY_PHASE1":114,"PHASE1":116,"PHASE2":118,"PHASE3":120,"PHASE4":122,"NA":124},{"trials":115,"activeCount":11},[],{"trials":117,"activeCount":11},[],{"trials":119,"activeCount":11},[],{"trials":121,"activeCount":11},[],{"trials":123,"activeCount":11},[],{"trials":125,"activeCount":11},[126],{"nctId":58,"briefTitle":59,"status":60,"phases":127,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":128,"interventions":129},[],[67,68],[42,70,71,72,73,72,74,75],{"intervention":73,"totalTrials":43,"cells":131},{"EARLY_PHASE1":132,"PHASE1":134,"PHASE2":136,"PHASE3":138,"PHASE4":140,"NA":142},{"trials":133,"activeCount":11},[],{"trials":135,"activeCount":11},[],{"trials":137,"activeCount":11},[],{"trials":139,"activeCount":11},[],{"trials":141,"activeCount":11},[],{"trials":143,"activeCount":11},[144],{"nctId":58,"briefTitle":59,"status":60,"phases":145,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":146,"interventions":147},[],[67,68],[42,70,71,72,73,72,74,75],{"intervention":74,"totalTrials":43,"cells":149},{"EARLY_PHASE1":150,"PHASE1":152,"PHASE2":154,"PHASE3":156,"PHASE4":158,"NA":160},{"trials":151,"activeCount":11},[],{"trials":153,"activeCount":11},[],{"trials":155,"activeCount":11},[],{"trials":157,"activeCount":11},[],{"trials":159,"activeCount":11},[],{"trials":161,"activeCount":11},[162],{"nctId":58,"briefTitle":59,"status":60,"phases":163,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":164,"interventions":165},[],[67,68],[42,70,71,72,73,72,74,75],{"intervention":75,"totalTrials":43,"cells":167},{"EARLY_PHASE1":168,"PHASE1":170,"PHASE2":172,"PHASE3":174,"PHASE4":176,"NA":178},{"trials":169,"activeCount":11},[],{"trials":171,"activeCount":11},[],{"trials":173,"activeCount":11},[],{"trials":175,"activeCount":11},[],{"trials":177,"activeCount":11},[],{"trials":179,"activeCount":11},[180],{"nctId":58,"briefTitle":59,"status":60,"phases":181,"primaryCompletion":62,"completion":63,"start":64,"enrollment":65,"conditions":182,"interventions":183},[],[67,68],[42,70,71,72,73,72,74,75],{"intervention":185,"totalTrials":43,"cells":186},"Hypercholesterolemic diet",{"EARLY_PHASE1":187,"PHASE1":189,"PHASE2":191,"PHASE3":193,"PHASE4":195,"NA":197},{"trials":188,"activeCount":11},[],{"trials":190,"activeCount":11},[],{"trials":192,"activeCount":11},[],{"trials":194,"activeCount":11},[],{"trials":196,"activeCount":11},[],{"trials":198,"activeCount":11},[199],{"nctId":200,"briefTitle":201,"status":60,"phases":202,"primaryCompletion":203,"completion":204,"start":205,"enrollment":206,"conditions":207,"interventions":208},"NCT01799720","Oxidized Omega-3 Supplements With Different Oxidation",[39],"2011-02","2011-04","2010-10",71,[31],[185],{"intervention":210,"totalTrials":43,"cells":211},"Standard treatment",{"EARLY_PHASE1":212,"PHASE1":214,"PHASE2":216,"PHASE3":218,"PHASE4":220,"NA":222},{"trials":213,"activeCount":11},[],{"trials":215,"activeCount":11},[],{"trials":217,"activeCount":11},[],{"trials":219,"activeCount":11},[],{"trials":221,"activeCount":11},[],{"trials":223,"activeCount":11},[224],{"nctId":225,"briefTitle":226,"status":227,"phases":228,"primaryCompletion":229,"completion":230,"start":229,"enrollment":231,"conditions":232,"interventions":234},"NCT06394336","Early Intervention With Therapeutic Exercise in Plantar Fasciopathy","UNKNOWN",[39],"2024-05-10","2025-02-10",60,[233],"Plantar Fascitis",[210]]